Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rocket Pharmaceuticals, Inc.

6.33
+0.18002.93%
Post-market: 6.400.0689+1.09%19:58 EDT
Volume:2.20M
Turnover:13.86M
Market Cap:674.97M
PE:-2.32
High:6.39
Open:6.13
Low:6.09
Close:6.15
Loading ...

Rocket Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
28 Feb

Rocket Pharmaceuticals: Expects Cash Resources Sufficient to Fund Operations Into Q3 2026

THOMSON REUTERS
·
28 Feb

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress

Business Wire
·
28 Feb

Selling Rocket Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

Simply Wall St.
·
26 Feb

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), CareDx (CDNA) and Intellia Therapeutics (NTLA)

TIPRANKS
·
14 Jan

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live
·
31 Dec 2024

Rocket Pharmaceuticals' Continued Pipeline Development to Support Long-Term Growth Potential, Wedbush Says

MT Newswires Live
·
31 Dec 2024

Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’

TIPRANKS
·
30 Dec 2024

Rocket Pharmaceuticals initiated with an Outperform at Wedbush

TIPRANKS
·
30 Dec 2024

Wedbush Initiates Rocket Pharmaceuticals at Outperform With $32 Price Target

MT Newswires Live
·
30 Dec 2024

Rocket Pharmaceuticals Inc : Wedbush Initiates Coverage With Outperform Rating; Price Target $32

THOMSON REUTERS
·
30 Dec 2024

Evercore ISI Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
23 Dec 2024

Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy'

Investopedia
·
19 Dec 2024

Jefferies Initiates Coverage on Rocket Pharmaceuticals With Buy Rating, $29 Price Target

MT Newswires Live
·
18 Dec 2024

Rocket Pharmaceuticals Initiated at Buy by Jefferies

Dow Jones
·
18 Dec 2024

Rocket Pharmaceuticals initiated with a Buy at Jefferies

TIPRANKS
·
18 Dec 2024

Rocket Pharmaceuticals price target lowered to $40 from $44 at Leerink

TIPRANKS
·
12 Dec 2024

Leerink Partners Adjusts Rocket Pharmaceuticals Price Target to $40 From $44, Maintains Outperform Rating

MT Newswires Live
·
12 Dec 2024

Rocket Pharmaceuticals Prices Upsized $165 Million Stock Offering

MT Newswires Live
·
11 Dec 2024

BUZZ-Rocket Pharmaceuticals falls after upsized $165 mln stock offering

Reuters
·
11 Dec 2024